Despite a number of new technologies introduced over the years, there remains a major unmet need for a methodology to objectively quantify adequacy of perfusion and oxygen delivery to tissues. More specifically clinical determination and quantification of circulatory shock remains imprecise and very subjective.
I am excited to see the development of the Opticyte cellular oximeter... I believe this is likely to prove a very sensitive early warning system for compensated shock. This technology would have wide application – not only to assessment of trauma patients in the emergency department, but for monitoring of a wide variety of patients at risk for hypoperfusion in the operating room and intensive care unit.
In neonatal sepsis and shock, a very high mortality rate exceeding 30% persists despite all the advances in Neonatal Intensive Care. This new medical instrument (CellSat™ 100) has the potential for detecting mild to moderate shock during the "Golden Hour" when the clinician still has the opportunity to reverse potentially fatal deterioration with current therapies.